Steerable ultrasound catheter

Information

  • Patent Grant
  • 11109884
  • Patent Number
    11,109,884
  • Date Filed
    Thursday, March 28, 2019
    5 years ago
  • Date Issued
    Tuesday, September 7, 2021
    3 years ago
  • Inventors
  • Original Assignees
    • Flowcardia, Inc. (Franklin Lakes, NJ, US)
  • Examiners
    • Woo; Julian W
    Agents
    • Dinsmore & Shohl LLP
Abstract
A catheter includes a catheter body (CB) having a CB proximal-portion, a CB distal-portion, and a CB lumen. The CB distal-portion has a CB distal end. The CB proximal-portion has a distally narrowing taper, wherein the CB distal-portion extends distally from the distally narrowing taper of the CB proximal-portion. The CB lumen extends through the CB proximal-portion and the CB distal-portion. An ultrasound transmission member (UTM) has a UTM distal end. The UTM extends longitudinally through the CB lumen. The UTM has a longitudinal taper that tapers toward the UTM distal end, and wherein the longitudinal taper tapers distally from the distally narrowing taper of the CB proximal-portion. A distal head (DH) is coupled with the UTM distal end and is disposed adjacent the CB distal end.
Description
BACKGROUND OF THE INVENTION

The present invention relates generally to medical devices and methods. More specifically, the present invention relates to ultrasound catheter devices and methods for treating occlusive intravascular lesions.


Catheters employing various types of ultrasound transmitting members have been successfully used to ablate or otherwise disrupt obstructions in blood vessels. Specifically, ablation of atherosclerotic plaque or thromboembolic obstructions from peripheral blood vessels such as the femoral arteries has been particularly successful. Various ultrasonic catheter devices have been developed for use in ablating or otherwise removing obstructive material from blood vessels. For example, U.S. Pat. Nos. 5,267,954 and 5,380,274, issued to an inventor of the present invention and hereby incorporated by reference, describe ultrasound catheter devices for removing occlusions. Other examples of ultrasonic ablation devices for removing obstructions from blood vessels include those described in U.S. Pat. No. 3,433,226 (Boyd), U.S. Pat. No. 3,823,717 (Pohlman, et at), U.S. Pat. No. 4,808,153 (Parisi), U.S. Pat. No. 4,936,281 (Stasz), U.S. Pat. No. 3,565,062 (Kuril), U.S. Pat. No. 4,924,863 (Sterzer), U.S. Pat. No. 4,870,953 (Don Michael, et al), and U.S. Pat. No. 4,920,954 (Alliger, et at), as well as other patent publications W087-05739 (Cooper), W089-06515 (Bernstein, et al.), W090-0130 (Sonic Needle Corp.), EP, EP316789 (Don Michael, et al.), DE3,821,836 (Schubert) and DE2438648 (Pohlman). While many ultrasound catheters have been developed, however, improvements are still being pursued.


Typically, an ultrasonic catheter system for ablating occlusive material includes three basic components: an ultrasound generator, an ultrasound transducer, and an ultrasound catheter. The generator converts line power into a high frequency current that is delivered to the transducer. The transducer contains piezoelectric crystals which, when excited by the high frequency current, expand and contract at high frequency. These small, high-frequency expansions (relative to an axis of the transducer and the catheter) are amplified by the transducer horn into vibrational energy. The vibrations are then transmitted from the transducer through the ultrasound catheter via an ultrasound transmission member (or wire) running longitudinally through the catheter. The transmission member transmits the vibrational energy to the distal end of the catheter where the energy is used to ablate or otherwise disrupt a vascular obstruction.


To effectively reach various sites for treatment of intravascular occlusions, ultrasound catheters of the type described above typically have lengths of about 150 cm or longer. To permit the advancement of such ultrasound catheters through small and/or tortuous blood vessels such as the aortic arch, coronary vessels, and peripheral vasculature of the lower extremities, the catheters (and their respective ultrasound transmission wires) must typically be sufficiently small and flexible. Also, due to attenuation of ultrasound energy along the long, thin, ultrasound transmission wire, a sufficient amount of vibrational energy must be applied at the proximal end of the wire to provide a desired amount of energy at the distal end.


A number of ultrasound catheter devices have been described, for example in U.S. patent application Ser. Nos. 10/229,371, 10/345,078, 10/375,903, and 10/410,617, which were previously incorporated by reference. Improvements, however, are always being sought. For example, it continues to be challenging to develop a catheter that is stiff enough to be pushable or “steerable” through vasculature yet flexible enough, at least along part of its length, to navigate small, tortuous blood vessels, such as the coronary arteries or tortuous peripheral vasculature. It is also sometimes difficult to manipulate currently available ultrasound catheter devices, for example to twist or torque the proximal end of the catheter to move the distal end in a way that helps with navigation through the vasculature. Passage of a guidewire through an ultrasound catheter may also be improved upon, such that the guidewire does not interfere with, and may even enhance, disruption of vascular occlusions.


Therefore, a need exists for improved ultrasound catheter devices and methods that provide ablation or disruption of vascular occlusions. Ideally, such ultrasound catheters would have enhanced ability to navigate through small, tortuous blood vessels such as the coronary arteries. It would also be advantageous to have catheters that could be easily manipulated by a user. Ideally, such devices would allow for passage of a guidewire without interfering with, and perhaps even enhancing, disruption of vascular occlusions. At least some of these objectives will be met by the present invention.


BRIEF SUMMARY OF THE INVENTION

Ultrasound catheter devices and methods provide enhanced disruption of blood vessel obstructions. Generally, ultrasound catheters include an elongate flexible catheter body with one or more lumens, an ultrasound transmission member extending longitudinally through the catheter body lumen, and a distal head coupled with the transmission member and positioned adjacent the distal end of the catheter body for disrupting occlusions. Improved features include but are not limited to catheter bodies and ultrasound transmission members with increasing flexibility toward their distal ends, devices that bend concomitantly with one or more bends in a guidewire and/or a blood vessel, a proximal housing coupled with an ultrasound catheter body for enhancing manipulation of the catheter body, a guidewire lumen configured to allow contact between a guidewire and an ultrasound transmission member, distal heads with improved guidewire lumens and the like.


In one aspect of the present invention, an ultrasound catheter for disrupting occlusions in blood vessels is provided, which can be guided from an access site on a patient's body to a target site adjacent an occlusion. The ultrasound catheter generally includes an elongate flexible catheter body, an ultrasound transmission member extending longitudinally through the lumen of the catheter body, a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body, and at least one coupling member for coupling the ultrasound transmission member with a source of ultrasound energy. The catheter body has a proximal portion, a distal portion and at least one lumen, the proximal portion being stiffer than the distal portion, and the distal portion being more flexible near the distal end of the catheter body than near the proximal portion of the catheter body. The ultrasound transmission member has a proximal end and a distal end and is more flexible near its distal end than near its proximal end. Thus, both the distal portion of the catheter body and the ultrasound transmission member are more flexible toward the distal end of the device.


The increasing flexibility of the catheter body and the ultrasound transmission wire toward the distal end of the catheter device may be achieved by any suitable fabrication method. In some embodiments, for example, the ultrasound transmission wire, catheter body, or both may be tapered, such that their cross-sectional diameters decrease distally. In one embodiment, for example, the cross-sectional diameter of a catheter body may range from between about 0.102 cm and about 0.178 cm along its proximal end to between about 0.076 cm and about 0.127 cm along its distal end, and the cross-sectional diameter of an ultrasound transmission member may range from between about 0.051 cm and about 0.102 cm near its proximal end to between about 0.013 cm and about 0.038 cm near its distal end. Additionally or alternatively, the wall thickness of the catheter body may decrease from proximal to distal. For example, in one embodiment, the wall thickness of a catheter body may measure about 0.007 cm to about 0.020 cm along its proximal portion and about 0.005 cm to about 0.013 cm along its distal portion. In these or other embodiments, various combinations of materials may be used to give the catheter body, transmission wire or both a desired flexibility profile. Providing an ultrasound catheter with a catheter body and ultrasound transmission wire that both increase in flexibility toward the distal end of the device will enhance navigation of the distal end of the device through tortuous blood vessels. In one embodiment, for example, the distal portion of the device will be sufficiently flexible to pass, without kinking, through at least 5 cm length of a blood vessel having at least one bend and an inner diameter of between about 2 mm and about 5 mm. A “tortuous vessel,” for the purposes of this application, means having at least one bend or curve, and the bend or curve may have any angle or radius of curvature. In some embodiments, for example, at least one bend in a vessel may have a radius of about 1.0 cm or less. In some instances, of course, a tortuous blood vessel will have multiple bends or curves.


In another aspect of the invention, an ultrasound catheter for disrupting occlusions in blood vessels which can be guided along a guidewire from an access site on a patient's body to a target site adjacent an occlusion includes an elongate flexible catheter body, an ultrasound transmission member extending longitudinally through the lumen of the catheter body, a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body, and at least one coupling member for coupling the ultrasound transmission member with a source of ultrasound energy. In this aspect, the catheter body has a proximal portion, a distal portion and at least one lumen, the proximal portion has a larger cross-sectional diameter than the distal portion, the proximal portion is sufficiently stiff to push the distal portion through a blood vessel having at least one bend, and the distal portion is sufficiently flexible to pass through the bend in the blood vessel. The ultrasound transmission member has a proximal end and a distal end, the cross-sectional diameter of the ultrasound transmission member is less near its distal end than near its proximal end, and a distal portion of the ultrasound transmission member is sufficiently flexible to pass through the bend in the blood vessel. Again, in some embodiments the wall of the catheter body may be thinner along the distal portion than along the proximal portion.


In another aspect of the present invention, an ultrasound catheter for disrupting occlusions in blood vessels which can be guided from an access site on a patient's body to a target site adjacent an occlusion includes an elongate flexible catheter body having a proximal portion, a distal portion and at least one lumen, an ultrasound transmission member extending longitudinally through the lumen of the catheter body, a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body, and at least one coupling member for coupling the ultrasound transmission member with a source of ultrasound energy. In this aspect, the distal portion of the catheter body is more flexible near a distal end of the catheter body than near the proximal portion of the catheter body, and the ultrasound transmission member is more flexible near its distal end than near its proximal end. Additionally, the distal portion of the catheter body and the ultrasound transmission member are sufficiently flexible to conform concomitantly with at least one bend in a guidewire extended through the at least one lumen.


By “conforming concomitantly” it is meant that the catheter body and the ultrasound transmission member conform to the at least one bend in the guidewire such that the catheter body, transmission member and guidewire bend at an approximately similar angle. In some embodiments, the distal portion of the catheter body and the ultrasound transmission wire are sufficiently flexible to conform concomitantly to multiple bends in the guidewire. Also in some embodiments, the distal portion of the catheter body and the ultrasound transmission member are sufficiently flexible to conform concomitantly to multiple bends in a blood vessel. In various embodiments, the catheter may be advanced over a guidewire, a guidewire may be passed through the catheter body, or the catheter body, ultrasound transmission wire and guidewire may be advanced through a blood vessel simultaneously. Thus, in various embodiments, the distal portion of the catheter body, the ultrasound transmission wire and the guidewire may be passed together or sequentially through the multiple bends in the blood vessel while conforming concomitantly to the multiple bends.


In another aspect of the present invention, an ultrasound catheter for disrupting occlusions in blood vessels which can be guided from an access site on a patient's body to a target site adjacent an occlusion includes an elongate flexible catheter body having a proximal portion, a distal portion and at least one lumen, an ultrasound transmission member extending longitudinally through the lumen of the catheter body, a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body, and at least one coupling member for coupling the ultrasound transmission member with a source of ultrasound energy. In this aspect, the distal portion of the catheter body has at least one bend, and at least one lumen, the proximal portion of the catheter body is stiffer than the distal portion, and the distal portion is more flexible near a distal end of the catheter body than near the proximal portion of the catheter body. The ultrasound transmission member is more flexible near its distal end than near its proximal end, the ultrasound transmission member conforms to the at least one bend in the distal portion of the catheter body, and the distal portion of the catheter body and the ultrasound transmission member are sufficiently flexible to conform concomitantly to at least one bend in a guidewire.


In still another aspect of the present invention, an ultrasound catheter for disrupting occlusions in blood vessels which can be guided from an access site on a patient's body to a target site adjacent an occlusion includes an elongate flexible catheter body having a proximal portion, a distal portion and at least one lumen, an ultrasound transmission member extending longitudinally through the lumen of the catheter body, a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body, and at least one coupling member for coupling the ultrasound transmission member with a source of ultrasound energy. In this aspect, the catheter body includes a guidewire tube disposed within the lumen, and the proximal portion of the body is stiffer than the distal portion. The guidewire tube includes at least one opening within the catheter body for providing contact between a guidewire extending through the guidewire tube and the ultrasound transmission member.


Allowing a guidewire to contact the ultrasound transmission member may facilitate passage of the guidewire into or through a vascular occlusion, by allowing a portion of the ultrasound energy transmitted by the transmission member to be transferred to the guidewire. In various embodiments, the guidewire may contact the transmission member near the proximal end of the catheter device, near the distal end, near the middle, or some combination thereof. In some embodiments, the guidewire tube includes two openings within the catheter body, to allow the transmission member to pass through the tube. Any other configuration for allowing contact between a guidewire and the ultrasound transmission member is also contemplated.


In another aspect of the present invention, an ultrasound catheter for disrupting occlusions in blood vessels which can be guided from an access site on a patient's body to a target site adjacent an occlusion includes an elongate flexible catheter body having a proximal portion, a distal portion and at least one lumen, an ultrasound transmission member extending longitudinally through the lumen of the catheter body, a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body, and at least one coupling member for coupling the ultrasound transmission member with a source of ultrasound energy. In this aspect, the distal head includes a guidewire aperture in the center of its distal end and a guidewire lumen extending through the distal head. The guidewire lumen, in tum, has a different longitudinal axis than the longitudinal axis of the catheter body.


Having a guidewire lumen that exits from the center of the distal head is advantageous for advancing the guidewire as well as the catheter device. Angling the guidewire lumen away from the longitudinal axis of the catheter body allows a guidewire and the ultrasound transmission member to pass through a narrower catheter body, thus decreasing the diameter of the catheter device and facilitating passage through tortuous vessels. In some embodiments, the guidewire lumen in the distal head includes a cavity in which a distal end of a guidewire tube of the catheter body is disposed. In some embodiments, the cavity extends through the distal end of the distal head, such that the distal end of the guidewire tube is flush with the distal end of the distal head. In other embodiments, the cavity extends partially through the distal head, such that the distal end of the guidewire tube is disposed proximal to the distal end of the distal head.


In another aspect of the present invention, an ultrasound catheter for disrupting occlusions in blood vessels which can be guided from an access site on a patient's body to a target site adjacent an occlusion includes an elongate flexible catheter body having a proximal portion, a distal portion and at least one lumen, an ultrasound transmission member extending longitudinally through the lumen of the catheter body, a distal head coupled with the distal end of the ultrasound transmission member and disposed adjacent the distal end of the catheter body, and at least one coupling member for coupling the ultrasound transmission member with a source of ultrasound energy. In this aspect of the invention, the at least one coupling member comprises a housing fixedly coupled with the proximal end of the catheter body such that torque applied to the housing is transmitted along the catheter body to its distal portion.


In yet another aspect of the invention, a method for disrupting an occlusion in a blood vessel involves: advancing an ultrasound catheter through a blood vessel having at least one bend, the catheter conforming concomitantly to the at least one bend, wherein advancing includes contacting an ultrasound transmission member of the ultrasound catheter with a guidewire at one or more locations within the catheter; positioning a distal end of the ultrasound catheter adjacent an occlusion in the blood vessel; and transmitting ultrasound energy to the ultrasound transmission member to disrupt the occlusion into multiple occlusion fragments, wherein transmitting includes transmitting ultrasound energy to the guidewire. Optionally, the method may further include removing at least some of the occlusion fragments from the blood vessel via the ultrasound catheter. In some embodiments, the ultrasound catheter is advanced along the guidewire. Alternatively, the guidewire may be passed through the catheter, or the catheter and the guidewire may be advanced together through the blood vessel. Positioning may also involve advancing the ultrasound catheter and the guidewire along multiple bends in the blood vessel, wherein a catheter body of the catheter, the ultrasound transmission member and the guidewire conform concomitantly to the multiple bends. Bends may have any suitable angle or radius of curvature. In one embodiment, for example, one or more bends may have a radius of about 1.0 cm or less. The method may also involve applying radial force to a proximal housing of the ultrasound catheter to radially tum the distal end of the ultrasound catheter in the blood vessel.


Further aspects and specific embodiments of the invention will be described below, in reference to the attached drawing figures.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a perspective view of an ultrasound catheter system including an ultrasound catheter device and ultrasound energy source according to an embodiment of the present invention;



FIG. 1A is a cross-sectional side view of an ultrasound catheter device according to one embodiment of the present invention;



FIG. 2 is a perspective view of a human heart and an ultrasound catheter device, showing one possible path along which a device may be advanced according to an embodiment of the present invention;



FIG. 3 is a cross-sectional side view of a portion of an ultrasound catheter device according to an embodiment of the present invention;



FIG. 4 is a cross-sectional side view of a distal portion of an ultrasound catheter device and a guidewire according to an embodiment of the present invention;



FIG. 5 is a cross-sectional side view of a distal portion of an ultrasound catheter device and a guidewire according to an embodiment of the present invention;



FIG. 6 is a cross-sectional side view of the distal end of the ultrasound catheter device and a guidewire shown in FIG. 5;



FIG. 7 is a cross-sectional side view of a distal end of an ultrasound catheter device and a guidewire according to an embodiment of the present invention; and



FIG. 8 is a perspective view of an ultrasound catheter device having a fixed proximal housing according to an embodiment of the present invention.





DETAILED DESCRIPTION OF THE INVENTION

Ultrasound catheter devices and methods of the present invention generally provide for enhanced treatment of occlusive intravascular lesions. Catheter devices generally include a catheter body, an ultrasound energy transmission member disposed within the catheter body and a distal head coupled with the energy transmission member and disposed adjacent the distal end of the catheter body. The ultrasound transmission member transmits ultrasound energy from an ultrasound transducer to the distal head, causing the head to vibrate and, thus, disrupt vascular occlusions. A number of improved features of such ultrasound catheter devices are described more fully below.


Referring now to FIG. 1, one embodiment of an ultrasound catheter system 20 suitably includes an ultrasound catheter device 10, including a proximal end connector 12 for coupling device 10 with an ultrasound transducer 14, and an ultrasound generator 16 coupled with transducer 14 and a foot-actuated on/off switch 18 to provide ultrasonic energy to transducer 14 and, thus, to ultrasound catheter 10. Generally, catheter 10 includes an ultrasound transmission member, or wire (not shown), for transmitting energy from the transducer 14 to a distal head 26 of catheter 10. In some embodiments, transducer 14 further includes a securing device 15 for enhancing coupling of catheter 10 to transducer 14. Components of system 20 may be coupled via any suitable means, such as connecting wires of any kind, wireless connections or the like.


In addition to proximal connector 12, ultrasound catheter device 10 may include one or more other various components, such as a Y-connector 11 or the like for providing access for irrigation, guidewire passage, suction or the like. Some embodiments of device include a monorail guidewire 13, some include a proximal guidewire port 17 for over the wire guidewire delivery, and some embodiments include both. In some embodiments, Y-connector may include an irrigation port, for providing access for an irrigation tube 24. Irrigation tube 24, in some embodiments, may be used for introducing one or more fluids, applying vacuum, or both. Generally, catheter device 10 may include any suitable number of side-aims or ports for passage of a guidewire, infusing and/or withdrawing irrigation fluid, dye and/or the like, or any other suitable ports or connections. Also, ultrasound catheters 10 of the present invention may be used with any suitable proximal devices, such as any suitable ultrasound transducer 14, ultrasound generator 16, coupling device(s) and/or the like. Therefore, exemplary FIG. 1 and any following descriptions of proximal apparatus or systems for use with ultrasound catheters 10 should not be interpreted to limit the scope of the present invention as defined in the appended claims.


Referring now to FIG. 1A, a cross-sectional side view of one embodiment of ultrasound catheter device 10 is shown. Generally, ultrasound catheter 10 suitably includes an elongate catheter body 22 with an ultrasound transmission member 24 disposed longitudinally through a catheter lumen 21 and ending in distal head (not shown). Catheter body 22 is generally a flexible, tubular, elongate member, having any suitable diameter and length for reaching a vascular occlusion for treatment. In one embodiment, for example, catheter body 22 preferably has an outer diameter of between about 0.5 mm and about 5.0 mm. In other embodiments, as in catheters intended for use in relatively small vessels, catheter body 22 may have an outer diameter of between about 0.25 mm and about 2.5 mm. Catheter body 22 may also have any suitable length. As discussed briefly above, for example, some ultrasound catheters have a length in the range of about 150 cm. However, any other suitable length may be used without departing from the scope of the present invention. Examples of catheter bodies similar to those which may be used in the present invention are described in U.S. Pat. Nos. 5,267,954 and 5,989,208, which were previously incorporated herein by reference.


In some embodiments, catheter body 22 is made from a polymeric material.


Sometimes the polymer will have a desired amount of flexibility, such as in one embodiment where catheter body 22 is made of a polymer having a flexural modulus of less than about 160 Psi. In some embodiments, such a polymer will be one of any number of polyether block amides, although other polymers may of course be used. In some embodiments, such polyether block amides may have a Shore D hardness value ranging from about 55 to about 75, while in other embodiments they may have a Shore D hardness value ranging from about 25 to about 55. In some embodiments, the polymeric material includes up to about 5 weight percent of a colorant.


In most embodiments, ultrasound transmission member 24, which may comprise a wire, wave guide or the like, extends longitudinally through catheter body lumen 21 to transmit ultrasonic energy from ultrasound transducer 14 (FIG. 1) to the distal end of catheter 10. Ultrasound transmission member 24 may be formed of any material capable of effectively transmitting ultrasonic energy from ultrasound transducer 14 to the distal end of catheter body 22, including but not limited to metals such as pure titanium or aluminum, or titanium or aluminum alloys. In accordance with one aspect of the invention, all or a portion of ultrasound transmission member 24 may be formed of one or more materials which exhibit superelastic properties. Such material(s) should preferably exhibit superelasticity consistently within the range of temperatures normally encountered by ultrasound transmission member 24 during operation of ultrasound catheter apparatus 10. For example, in some embodiments, the material is an alloy having a tensile strength of between about 170,000 Psi and about 250,000 Psi. In some embodiments, the alloy exhibits elongation of between about 7% and about 17%. For example, in some embodiments the alloy is a nickel-titanium alloy having nickel content of between about 50.50 and about 51.50 atomic weight.


Use of superelastic metal alloys in ultrasound transmission members is described in U.S. Pat. No. 5,267,954, previously incorporated by reference. Examples of superelastic metal alloys which may be used are described in detail in U.S. Pat. No. 4,665,906 (Jervis); U.S. Pat. No. 4,565,589 (Harrison); U.S. Pat. No. 4,505,767 (Quin); and U.S. Pat. No. 4,337,090 (Harrison), the entire disclosures of which are hereby incorporated by reference insofar as they describe the compositions, properties, chemistries and behavior of specific metal alloys which are superelastic within the temperature range at which ultrasound transmission member 24 of the present invention operates, any and all of which superelastic metal alloys may be used to form ultrasound transmission member 24 of the present invention. In some embodiments, for example, the alloy exhibits a superelastic temperature range of about 10 degrees Celsius to about 50 degrees Celsius.


With continued reference to FIG. 1A, one embodiment of proximal end connector 12 suitably includes a housing 42 with a hollow inner bore 44. Bore 44 may have a uniform inner diameter along its length or, alternatively, may have multiple segments, such as a proximal segment 47, a middle segment 45 and a distal segment 49, each of which may surround one or more various components of proximal end connector 12. Generally, proximal segment 47 of bore 44 is configured to allow coupling with ultrasound transducer 14 (not shown) via any suitable coupling means, such as a pressure fit, complementary threads or the like. Proximal segment 47 includes a sonic connector 52 for transmitting vibrational energy from transducer 14 to ultrasound transmission member 24. Sonic connector 52 may be held within housing 42 by any suitable means. In some embodiments, for example, a dowel pin may extend through sonic connector 52 to hold it within housing 42. In another embodiment, sonic connector 52 may be secured within housing 42 by means of a cavity in housing 42.


Middle segment 45 of bore 44, in some embodiments, may surround a portion of sonic connector 52, while in other embodiments, sonic connector 52 may be housed only within proximal segment 47. Sonic connector 52 is coupled with the proximal end of ultrasound transmission member 24 by any suitable means for transmitting ultrasound energy to transmission member 24 from transducer 14. Absorber members 50, such as O-rings, surround a portion of ultrasound transmission member 24 for providing absorption of transverse vibration. Absorber members 50 may be used in any number or combination and have any suitable size and configuration, depending on the desired level of vibration absorption or dampening. Alternatively or additionally, other dampening structures may be used. Thus, the invention is not limited to the combination shown in FIG. 1A.


Distal segment 49 of bore 44 typically surrounds a portion of ultrasound transmission member 24 and may also contain one or more additional sets of absorber members 50. Distal segment 49 may also contain a portion of a Y-connector 11, which is coupled with the distal end of housing 42. Coupling ofY-connector 11 with the distal end of housing 42 may be accomplished via complementary threads, pressure fitting, or any other suitable means. A Y-connector lumen 48 of Y-connector 11 allows passage of ultrasound transmission member 24 and is in fluid communication with catheter body lumen 21.


Generally, pressurized fluid such as a coolant liquid may be infused through a sidearm 13 of Y-connector, through Y-connector lumen 48 and through catheter body lumen 21 so that it flows out of one or more fluid outflow apertures in distal head 26. The temperature and flow rate of such coolant liquid may be specifically controlled to maintain the temperature of ultrasound transmission member 24 at a desired temperature within its optimal working range. In particular, in embodiments of the invention wherein ultrasound transmission member 24 is formed of a metal alloy which exhibits optimal physical properties (e.g. super elasticity) within a specific range of temperatures, the temperature and flow rate of coolant liquid infused through fluid infusion side-arm 13 may be specifically controlled to maintain the temperature of ultrasound transmission member 24 within a range of temperatures at which it demonstrates its most desirable physical properties. For example, in embodiments of the invention wherein ultrasound transmission member 24 is formed of a shape memory alloy which exhibits super elasticity when in its martensite state, but which loses super elasticity as it transitions to an austenite state, it will be desirable to adjust the temperature and flow rate of the coolant liquid infused through fluid infusion side-arm 13 so as to maintain the shape memory alloy of ultrasound transmission member 24 within a temperature range at which the alloy will remain in its martensite state and will not transition to an austenite state. The temperature at which such shape memory alloys transition from a martensite state to an austenite state is known as the “martensite transition temperature” of the material. Thus, in these embodiments, the fluid infused through side-arm 13 will be at such temperature, and will be infused at such rate, as to maintain the shape memory alloy of ultrasound transmission member 24 below its martensite transition temperature.


Referring now to FIG. 2, an ultrasound catheter device 100 may be used in to treat one or more coronary arteries CA in a human heart H. Some embodiments include a flexible distal portion configured to navigate one or more bends 102 in a coronary artery CA or other vessel. In some embodiments, catheter device 100 will be positioned in a coronary artery CA or other vessel by advancing it over (or along with) a guidewire 104. Some embodiments may also include or be used with a guide catheter 106.


As mentioned above, a “tortuous blood vessel,” for the purposes of this application, means a vessel having at least one bend (which may also be referred to as a “curve” or the like), having any angle of curvature. In some cases, of course, tortuous vessels also have relatively small inner diameters and multiple bends, and various embodiments of ultrasound catheter device 100 are configured to navigate multiple bends in a vessel. In some embodiments, ultrasound catheter device 100 is configured to conform to one or more bends in a vessel such that two or more components of the device bend concomitantly with one another. For example, in some embodiments, when device 100 extends through a bend in a vessel, an ultrasound transmission member and a catheter body of device 100 will bend with approximately the same angle. In some embodiments, the ultrasound transmission member, the catheter body and a guidewire extending through the catheter may all bend concomitantly to conform to a bend in a blood vessel. Such concomitant bending is in contrast with some prior art devices, wherein the ultrasound transmission member, for example, is relatively stiffer than a distal portion of the catheter body, so that when the device is placed in a bend in a blood vessel, the catheter body bends at a more acute angle than the transmission member.


Referring now to FIG. 3, in one embodiment an ultrasound catheter device 110 of the present invention includes a catheter body 116 having a proximal portion 112 and a distal portion 114, an ultrasound transmission member 118, and a distal head Ill. As discussed above, catheter body 116, transmission member 118 and distal head 111 may be fabricated from any suitable material(s) and may have any of a number of suitable configurations, dimensions, and the like. In fact, FIG. 3 is not drawn to scale, and distal portion 114, for example, may be relatively much longer than shown in FIG. 3.


Proximal portion 112 of catheter body 116 is generally stiffer than distal portion 114, such proximal portion 112 is used for pushing or steering, and distal portion 114 is sufficiently flexible to navigate through a tortuous blood vessel to reach an occlusion site. The difference in stiffness/flexibility may be achieved by using different materials for the different portions, by configuring proximal portion 112 with a thicker wall than distal portion 114, by giving proximal portion 112 a larger outer diameter, any combination of these, or any other suitable technique. In some embodiments, proximal portion 112 and distal portion 114 are made from one piece of material, or one extrusion, while in other embodiments two or more pieces of material may be joined together. Ultrasound transmission member 118 also becomes more flexible (less stiff) toward its distal end. This is typically achieved by tapering transmission member 118, and the taper may be gradual, as shown in FIG. 3, or may be achieved in one or more less-gradual steps. By providing catheter body 116 and ultrasound transmission member 118 with progressively increasing flexibility toward the distal end, catheter device 110 may provide enhanced “pushability” or “steerability,” while also facilitating navigation of tortuous vessels with distal portion 114.


With reference now to FIG. 4, another embodiment of an ultrasound catheter device 120 includes a catheter body 126, an ultrasound transmission member 128 and a guidewire tube 124 disposed within body 126, and a distal head coupled with ultrasound transmission member 121. Guidewire tube 124 may enter catheter body 126 at any suitable location and may extend distally up to, partially through, or completely through distal head 121, as will be explained more fully below. In one embodiment, guidewire tube 124 includes at least one opening 125 disposed within catheter body 126, for allowing a guidewire 122 to contact ultrasound transmission member 128 at one or more locations. In the embodiment shown, guidewire tube 124 includes two openings 125 to allow ultrasound transmission member 128 to pass through tube 124. Any other suitable opening(s) is also contemplated within the scope of the invention. By allowing guidewire 122 to contact ultrasound transmission member 128, an amount of ultrasound energy may be transferred from transmission member 128 to guidewire 122. This transferred energy may cause guidewire 122 to vibrate, and such vibrational energy may enhance the ability of guidewire 122 to cross a vascular occlusion. In many procedures, it is often advantageous to penetrate or cross an occlusion with guidewire 122, and utilizing ultrasound energy transferred to guidewire 122 from transmission member 128 will enhance such procedures.


Referring now to FIGS. 5 and 6, another embodiment of an ultrasound catheter device 130 suitably includes a catheter body 136, an ultrasound transmission member 138 and a guidewire tube 134 disposed within catheter body 136, and a distal head 131 coupled with the distal ends of transmission member 128 and guidewire tube 134. In this embodiments, distal head 131 includes a guidewire lumen 135. Guidewire lumen 135 has a cavity at its proximal end for accepting the distal end of guidewire tube 134. In alternative embodiments, distal head 131 may not include a cavity, and guidewire tube 134 may abut the proximal end of distal head 131, or the cavity may extend all the way through distal head 131, so that guidewire tube 134 extends all the way through distal head 131 and is flush with the distal end of distal head 131. Also in the embodiment depicted in FIGS. 5 and 6, guidewire lumen 135 of distal head 131 has a longitudinal axis 139 which is not parallel to the overall longitudinal axis 137 of catheter device 130. Thus, at least a distal portion of guidewire tube 134 is also disposed on the longitudinal axis 139 that is not parallel to the catheter device's 130 longitudinal axis 137. At the same time, guidewire lumen 135 of distal head 131 exits approximately at the center of the distal end of distal head 131. Typically, it is advantageous to have guidewire 132 exit approximately the center of distal head 131, to facilitate tracking of catheter device 130 along guidewire 132. It may also be advantageous, however, to offset guidewire tube 134 within catheter body 136, so that guidewire tube 134 and ultrasound transmission member 138 may fit within a catheter body having a smaller inner diameter. Smaller diameter catheters, of course, are more easily advanced through tortuous vasculature.


Generally, any coupled components described above may be coupled by any suitable means, such as adhesives, complementary threaded members, pressure fittings, and the like. For example, distal head 131 may be coupled with ultrasound transmission member 138, guidewire tube 134, and/or catheter body 136 with any suitable adhesive substance or via welding, bonding, pressure fitting, threaded fittings or the like. Adhesives may include, but are not limited to cyanoacrylate (eg. Loctite™, Loetite Corp., Ontario, CANADA or Dron Alpha™, Borden, Inc., Columbus, Ohio) or polyurethane (e.g. Dymax™, Dymax Engineering Adhesive, Torrington, Conn.) adhesives. Some embodiments may also include one or more anchoring members for further securing distal head 131 to the ultrasound catheter device 130. Examples of such anchoring members are described more fully in U.S. patent application Ser. No. 10/410,617, which was previously incorporated by reference.


Referring now to FIG. 7, another embodiment of an ultrasound catheter device 140 includes a catheter body 146, ultrasound transmission member 148, guidewire tube 144 and distal head 141 having a guidewire lumen 145. In this embodiment, as mentioned briefly above, guidewire lumen 145 is configured such that guidewire tube 144 extends through the whole length of distal head 141 and ends flush with the distal end of distal head 141. Generally, distal head 141 and guidewire lumen 145 may have any suitable sizes, shapes, configurations, dimensions and the like, and the invention is in no way limited by the embodiments shown.


With reference now to FIG. 8, some embodiments of an ultrasound catheter device 150 include a proximal housing 152 that is fixedly coupled with a catheter body 156. Housing 152 may be a handle, a coupling member for coupling the device 150 to an ultrasound transducer, or any other suitable proximal device for allowing a user to manipulate catheter device 150. By providing fixed coupling between housing 152 and catheter body, a proximal rotational force 155a (or torque, or twisting) applied at housing 152 will be transmitted to catheter body 156 to cause the distal end of catheter body 156 and distal head 151 to rotate 155b. It has been found that torquing, twisting or rotating ultrasound catheter device 150 may facilitate navigation of the device through tortuous vasculature and/or dissolution of a vascular occlusion using the device.


Although the invention has been described above with specific reference to various embodiments and examples, it should be understood that various additions, modifications, deletions and alterations may be made to such embodiments without departing from the spirit or scope of the invention. Accordingly, it is intended that all reasonably foreseeable additions, deletions, alterations and modifications be included within the scope of the invention as defined in the following claims.

Claims
  • 1. A catheter, comprising: a proximal end connector; a catheter body (CB) having a CB proximal-portion extending from the proximal end connector, a CB distal-portion, and a CB lumen, the CB distal-portion having a CB distal end, the CB proximal-portion having a distally narrowing taper, wherein the CB distal-portion extends distally from the distally narrowing taper of the CB proximal-portion, the CB lumen extends through the CB proximal-portion and the CB distal-portion, each of the CB proximal-portion and the CB distal-portion is configured for navigation through a blood vessel;an ultrasound transmission member (UTM) having a UTM distal end, the UTM extending longitudinally through the CB lumen, the UTM having a longitudinal taper that tapers toward the UTM distal end, and wherein the longitudinal taper tapers distally from the distally narrowing taper of the CB proximal-portion; anda distal head (DH) coupled with the UTM distal end and disposed adjacent the CB distal end.
  • 2. The catheter of claim 1, the UTM having a UTM proximal end, and further comprising a coupler disposed at the UTM proximal end and adapted to connect to an ultrasound energy source.
  • 3. The catheter of claim 1, wherein the CB distal-portion is sufficiently flexible to pass, without kinking, through a bent, blood-vessel length having an inner diameter that is from about 2 to 5 mm, wherein the bent, blood-vessel length is about 5 cm or longer.
  • 4. The catheter of claim 1, wherein the CB distal-portion is sufficiently flexible to pass, without kinking, through a bent, blood-vessel length that has a radius of about 1 cm or smaller.
  • 5. The catheter of claim 1 wherein: a CB proximal-portion diameter is from about 0.102 cm to about 0.178 cm and a CB distal-portion diameter is from about 0.076 cm to about 0.127 cm, anda UTM proximal-portion diameter is from about 0.051 cm to about 0.102 cm and a UTM distal-portion diameter is from about 0.013 cm to about 0.038 cm.
  • 6. The catheter of claim 1, wherein a CB proximal-portion wall thickness is from about 0.007 cm to about 0.020 cm and a CB distal-portion wall thickness is from about 0.005 cm to about 0.013 cm.
  • 7. The catheter of claim 1, wherein the DH has a distal head (DH) lumen adapted to receive a guidewire along an axis that is not parallel to a longitudinal axis of the CB distal-portion.
  • 8. The catheter of claim 1, wherein the CB proximal-portion is stiffer than the CB distal-portion and the CB distal-portion is more flexible near the CB distal end than near the CB proximal-portion.
  • 9. The catheter of claim 8, wherein the CB distal-portion is sufficiently flexible to pass, without kinking, through a bent, blood-vessel length having an inner diameter that is from about 2 to 5 mm, wherein the bent, blood-vessel length is about 5 cm or longer.
  • 10. The catheter of claim 9, wherein: a CB proximal-portion diameter is from about 0.102 cm to about 0.178 cm and a CB distal-portion diameter is from about 0.076 cm to about 0.127 cm, anda UTM proximal-portion diameter is from about 0.051 cm to about 0.102 cm and a UTM distal-portion diameter is from about 0.013 cm to about 0.038 cm.
  • 11. The catheter of claim 10, wherein a CB proximal-portion wall thickness is from about 0.007 cm to about 0.020 cm and a CB distal-portion wall thickness is from about 0.005 cm to about 0.013 cm.
  • 12. The catheter of claim 1, wherein the CB proximal-portion is configured to steer the CB distal-portion through a bent, blood-vessel length.
  • 13. The catheter of claim 1, wherein the CB proximal-portion and the CB distal-portion are made of a singular piece of material, the CB distal-portion has a CB distal-portion length and a constant diameter taken at any point selected from the CB distal-portion length.
  • 14. A catheter, comprising: a proximal end connector; a catheter body (CB) having at least one CB lumen, a a CB proximal-portion extending from the proximal end connector, a CB distal-portion, and a CB distal end, the CB proximal-portion comprising a distally narrowing taper, the CB distal portion extending from the distally narrow taper of the CB proximal-portion; andan ultrasound transmission member (UTM) extending longitudinally through the at least one CB lumen,wherein a CB proximal-portion diameter is from about 0.102 cm to about 0.178 cm and a CB distal-portion diameter is from about 0.076 cm to about 0.127 cm, and a UTM proximal-portion diameter is from about 0.051 cm to about 0.102 cm and a UTM distal-portion diameter is from about 0.013 cm to about 0.038 cm.
  • 15. The catheter of claim 14, comprising a distal head (DH) coupled with a UTM distal end and disposed adjacent the CB distal end.
  • 16. The catheter of claim 15, wherein the DH has a distal head (DH) lumen adapted to receive a guidewire along an axis that is not parallel to a longitudinal axis of the CB distal-portion.
  • 17. The catheter of claim 14, comprising a housing fixed to the CB proximal-portion such that torque applied to the housing is transmitted along the CB to the CB distal end.
  • 18. The catheter of claim 14, wherein a CB proximal-portion wall thickness is from about 0.007 cm to about 0.020 cm and a CB distal-portion wall thickness is from about 0.005 cm to about 0.013 cm.
  • 19. The catheter of claim 14, wherein the CB proximal-portion is stiffer than the CB distal-portion and the CB distal-portion is more flexible near the CB distal end than near the CB proximal-portion, and the CB distal-portion has a plurality of diameters, a first diameter selected from the plurality of diameters is equal in length to any of the plurality of diameters.
  • 20. The catheter of claim 14, wherein the CB distal-portion is sufficiently flexible to pass, without kinking, through a bent, blood-vessel length having an inner diameter that is from about 2 to 5 mm, wherein the bent, blood-vessel length is about 5 cm or longer.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/229,034, filed Aug. 4, 2016, now U.S. Pat. No. 10,285,727), which is a divisional of U.S. patent application Ser. No. 14/201,649, filed Mar. 7, 2014, (now U.S. Pat. No. 9,421,024), which is a continuation of U.S. patent application Ser. No. 12/036,870, filed Feb. 25, 2008, (now U.S. Pat. No. 8,668,709), which is a divisional of U.S. patent application Ser. No. 10/722,209, filed Nov. 24, 2003, (now U.S. Pat. No. 7,335,180), entitled “Steerable Ultrasound Catheter.” This application is also related to the following U.S. patents and applications, the full disclosures of which are all hereby incorporated by reference: U.S. patent application Ser. No. 14/139,447, filed Dec. 23, 2013, (now U.S. Pat. No. 9,381,027), entitled “Ultrasound Catheter for Disrupting Blood Vessel Obstructions”; U.S. patent application Ser. No. 12/021,082, filed Jan. 28, 2008, (now U.S. Pat. No. 8,613,751), entitled “Ultrasound Catheter for Disrupting Blood Vessel Obstructions”; U.S. patent application Ser. No. 10/229,371, filed Aug. 26, 2002, (now U.S. Pat. No. 7,137,963), entitled “Ultrasound Catheter for Disrupting Blood Vessel Obstructions”; U.S. patent application Ser. No. 10/345,078, filed Jan. 14, 2003, (now U.S. Pat. No. 7,604,608), entitled “Ultrasound Catheter and Methods for Making and Using Same”; U.S. patent application Ser. No. 10/375,903, filed Feb. 26, 2003, (now U.S. Pat. No. 6,942,677), entitled “Ultrasound Catheter Apparatus”; and U.S. patent application Ser. No. 10/410,617, filed Apr. 8, 2003, (now U.S. Pat. No. 7,220,233), entitled “Improved Ultrasound Catheter Devices and Methods.”

US Referenced Citations (512)
Number Name Date Kind
3296620 Rodda Jan 1967 A
3433226 Boyd Mar 1969 A
3443226 Knight May 1969 A
3565062 Kurls Feb 1971 A
3585082 Siller Jun 1971 A
3612038 Halligan Oct 1971 A
3631848 Muller Jan 1972 A
3679378 Van Impe et al. Jul 1972 A
3719737 Vaillancourt et al. Mar 1973 A
3739460 Addis et al. Jun 1973 A
3754746 Thiele Aug 1973 A
3823717 Pohlman et al. Jul 1974 A
3835690 Leonhardt et al. Sep 1974 A
3839841 Amplatz Oct 1974 A
3896811 Storz Jul 1975 A
4016882 Broadwin et al. Apr 1977 A
4033331 Guss et al. Jul 1977 A
4136700 Broadwin et al. Jan 1979 A
4337090 Harrison Jun 1982 A
4368410 Hance et al. Jan 1983 A
4417578 Banko Nov 1983 A
4425115 Wuchinich Jan 1984 A
4449523 Szachowicz et al. May 1984 A
4453935 Newton Jun 1984 A
4486680 Bonnet et al. Dec 1984 A
4505767 Quin Mar 1985 A
4535759 Polk et al. Aug 1985 A
4545767 Suzuki et al. Oct 1985 A
4565589 Harrison Jan 1986 A
4565787 Bossle et al. Jan 1986 A
4572184 Stohl et al. Feb 1986 A
4664112 Kensey et al. May 1987 A
4665906 Jervis May 1987 A
4679558 Kensey et al. Jul 1987 A
4700705 Kensey et al. Oct 1987 A
4721117 Mar et al. Jan 1988 A
4750902 Wuchinich et al. Jun 1988 A
4781186 Simpson et al. Nov 1988 A
4808153 Parisi Feb 1989 A
4811743 Stevens Mar 1989 A
4827911 Broadwin et al. May 1989 A
4838853 Parisi Jun 1989 A
4854325 Stevens Aug 1989 A
4870953 DonMicheal et al. Oct 1989 A
4886060 Wiksell Dec 1989 A
4920954 Alliger et al. May 1990 A
4923462 Stevens May 1990 A
4924863 Sterzer May 1990 A
4931047 Broadwin et al. Jun 1990 A
4936281 Stasz Jun 1990 A
4936845 Stevens Jun 1990 A
4979952 Kubota et al. Dec 1990 A
5000185 Yock Mar 1991 A
5015227 Broadwin et al. May 1991 A
5026384 Farr et al. Jun 1991 A
5030201 Palestrant Jul 1991 A
5030357 Lowe Jul 1991 A
5046503 Schneiderman Sep 1991 A
5053008 Bajaj Oct 1991 A
5058570 Idemoto et al. Oct 1991 A
5076276 Sakurai et al. Dec 1991 A
5091205 Fan Feb 1992 A
5100423 Fearnot Mar 1992 A
5109859 Jenkins May 1992 A
5114414 Buchbinder May 1992 A
5116350 Stevens May 1992 A
5127917 Niederhauser et al. Jul 1992 A
5131393 Ishiguro et al. Jul 1992 A
5156143 Bocquet et al. Oct 1992 A
5163421 Bernstein et al. Nov 1992 A
5171216 Dasse et al. Dec 1992 A
5180363 Idemoto et al. Jan 1993 A
5183470 Wettermann Feb 1993 A
5195955 Don Michael Mar 1993 A
5215614 Wijkamp et al. Jun 1993 A
5217565 Kou et al. Jun 1993 A
5221255 Mahurkar et al. Jun 1993 A
5226421 Frisbie et al. Jul 1993 A
5234416 Macaulay et al. Aug 1993 A
5236414 Takasu Aug 1993 A
5238004 Sahatjian et al. Aug 1993 A
5242385 Strukel Sep 1993 A
5243997 Uflacker et al. Sep 1993 A
5248296 Alliger Sep 1993 A
5255669 Kubota et al. Oct 1993 A
5267954 Nita Dec 1993 A
5269291 Carter Dec 1993 A
5269297 Weng et al. Dec 1993 A
5269793 Simpson Dec 1993 A
5279546 Mische et al. Jan 1994 A
5287858 Hammerslag et al. Feb 1994 A
5290229 Paskar Mar 1994 A
5304115 Pflueger et al. Apr 1994 A
5304131 Paskar Apr 1994 A
5312328 Nita et al. May 1994 A
5318014 Carter Jun 1994 A
5318570 Hood et al. Jun 1994 A
5324255 Passafaro et al. Jun 1994 A
5324260 O'Neill et al. Jun 1994 A
5325860 Seward et al. Jul 1994 A
5326342 Pflueger et al. Jul 1994 A
5328004 Fannin et al. Jul 1994 A
5329927 Gardineer et al. Jul 1994 A
5341818 Abrams et al. Aug 1994 A
5342292 Nita et al. Aug 1994 A
5344395 Whalen et al. Sep 1994 A
5346502 Estabrook et al. Sep 1994 A
5362309 Carter Nov 1994 A
5368557 Nita Nov 1994 A
5368558 Nita et al. Nov 1994 A
5376084 Bacich et al. Dec 1994 A
5378234 Hammerslag et al. Jan 1995 A
5380274 Nita Jan 1995 A
5380316 Aita et al. Jan 1995 A
5382228 Nita et al. Jan 1995 A
5383460 Jang et al. Jan 1995 A
5389096 Aita et al. Feb 1995 A
5391144 Sakurai et al. Feb 1995 A
5397293 Alliger et al. Mar 1995 A
5397301 Pflueger et al. Mar 1995 A
5403324 Ciervo et al. Apr 1995 A
5405318 Nita Apr 1995 A
5409483 Campbell et al. Apr 1995 A
5417672 Nita et al. May 1995 A
5417703 Brown et al. May 1995 A
5421923 Clarke et al. Jun 1995 A
5427118 Nita et al. Jun 1995 A
5431168 Webster, Jr. Jul 1995 A
5431663 Carter Jul 1995 A
5443078 Uflacker Aug 1995 A
5447509 Mills et al. Sep 1995 A
5449369 Imran Sep 1995 A
5449370 Vaitekunas Sep 1995 A
5451209 Ainsworth et al. Sep 1995 A
5462529 Simpson et al. Oct 1995 A
5465733 Hinohara et al. Nov 1995 A
5474530 Passafaro et al. Dec 1995 A
5474531 Carter Dec 1995 A
5480379 La Rosa Jan 1996 A
5484398 Stoddard Jan 1996 A
5487757 Truckai et al. Jan 1996 A
5498236 Dubrul et al. Mar 1996 A
5507738 Ciervo Apr 1996 A
5516043 Manna et al. May 1996 A
5527273 Manna et al. Jun 1996 A
5538512 Zenzon et al. Jul 1996 A
5540656 Pflueger et al. Jul 1996 A
5542917 Nita et al. Aug 1996 A
5597497 Dean et al. Jan 1997 A
5597882 Schiller et al. Jan 1997 A
5607421 Jeevanandam et al. Mar 1997 A
5611807 O'Boyle Mar 1997 A
5618266 Liprie Apr 1997 A
5626593 Imran May 1997 A
5627365 Chiba et al. May 1997 A
5649935 Kremer et al. Jul 1997 A
5658282 Daw et al. Aug 1997 A
5665062 Houser Sep 1997 A
5685841 Mackool Nov 1997 A
5695460 Siegel et al. Dec 1997 A
5695507 Auth et al. Dec 1997 A
5715825 Crowley Feb 1998 A
5720724 Ressemann et al. Feb 1998 A
5725494 Brisken Mar 1998 A
5728062 Brisken Mar 1998 A
5738100 Yagami et al. Apr 1998 A
5797876 Spears et al. Aug 1998 A
5816923 Milo et al. Oct 1998 A
5827203 Nita Oct 1998 A
5827971 Hale et al. Oct 1998 A
5830127 DeCastro Nov 1998 A
5830222 Makower Nov 1998 A
5846218 Brisken et al. Dec 1998 A
5873835 Hastings et al. Feb 1999 A
5876385 Ikari et al. Mar 1999 A
5893838 Daoud et al. Apr 1999 A
5895397 Jang Apr 1999 A
5902287 Martin May 1999 A
5904667 Falwell May 1999 A
5916192 Nita et al. Jun 1999 A
5916912 Ames et al. Jun 1999 A
5935142 Hood Aug 1999 A
5935144 Estabrook Aug 1999 A
5937301 Gardner et al. Aug 1999 A
5944737 Tsonton et al. Aug 1999 A
5957882 Nita et al. Sep 1999 A
5957899 Spears et al. Sep 1999 A
5964223 Baran Oct 1999 A
5967984 Chu et al. Oct 1999 A
5971949 Levin et al. Oct 1999 A
5976119 Spears et al. Nov 1999 A
5989208 Nita Nov 1999 A
5989275 Estabrook et al. Nov 1999 A
5997497 Nita et al. Dec 1999 A
6004280 Buck et al. Dec 1999 A
6004335 Vaitekunas et al. Dec 1999 A
6007499 Martin et al. Dec 1999 A
6007514 Nita Dec 1999 A
6022309 Celliers et al. Feb 2000 A
6024764 Schroeppel Feb 2000 A
6029671 Stevens et al. Feb 2000 A
6030357 Daoud et al. Feb 2000 A
6036689 Tu et al. Mar 2000 A
6051010 DiMatteo et al. Apr 2000 A
6066135 Honda May 2000 A
6113558 Rosenschein et al. Sep 2000 A
6120515 Rogers et al. Sep 2000 A
6123698 Spears et al. Sep 2000 A
6142971 Daoud et al. Nov 2000 A
6149596 Bancroft Nov 2000 A
6159176 Broadwin et al. Dec 2000 A
6159187 Park Dec 2000 A
6165127 Crowley Dec 2000 A
6165188 Saadat et al. Dec 2000 A
6179809 Khairkhahan et al. Jan 2001 B1
6180059 Divino, Jr. et al. Jan 2001 B1
6190353 Makower et al. Feb 2001 B1
6206842 Tu et al. Mar 2001 B1
6210356 Anderson et al. Apr 2001 B1
6217543 Anis et al. Apr 2001 B1
6217565 Cohen Apr 2001 B1
6217588 Jerger et al. Apr 2001 B1
6221015 Yock Apr 2001 B1
6231546 Milo et al. May 2001 B1
6231587 Makower May 2001 B1
6235007 Divino, Jr. et al. May 2001 B1
6241692 Tu et al. Jun 2001 B1
6241703 Levin et al. Jun 2001 B1
6241744 Imran et al. Jun 2001 B1
6248087 Spears et al. Jun 2001 B1
6277084 Abele et al. Aug 2001 B1
6283983 Makower et al. Sep 2001 B1
6287271 Dubrul et al. Sep 2001 B1
6287285 Michal et al. Sep 2001 B1
6287317 Makower et al. Sep 2001 B1
6296620 Gesswein et al. Oct 2001 B1
6298620 Hatzinikolas Oct 2001 B1
6302875 Makower et al. Oct 2001 B1
6309358 Okubo Oct 2001 B1
6315741 Martin et al. Nov 2001 B1
6315754 Daoud et al. Nov 2001 B1
6331171 Cohen Dec 2001 B1
6346192 Buhr et al. Feb 2002 B2
6379378 Werneth et al. Apr 2002 B1
6387109 Davison et al. May 2002 B1
6387324 Patterson et al. May 2002 B1
6394956 Chandrasekaran et al. May 2002 B1
6398736 Seward Jun 2002 B1
6409673 Yock Jun 2002 B2
6416533 Gobin et al. Jul 2002 B1
6423026 Gesswein et al. Jul 2002 B1
6427118 Suzuki Jul 2002 B1
6433464 Jones Aug 2002 B2
6434418 Neal et al. Aug 2002 B1
6450975 Brennan et al. Sep 2002 B1
6454737 Nita et al. Sep 2002 B1
6454757 Nita et al. Sep 2002 B1
6454997 Divino, Jr. et al. Sep 2002 B1
6484052 Visuri et al. Nov 2002 B1
6491707 Makower et al. Dec 2002 B2
6494891 Cornish et al. Dec 2002 B1
6494894 Mirarchi Dec 2002 B2
6500141 Irion et al. Dec 2002 B1
6508781 Brennan et al. Jan 2003 B1
6508784 Shu Jan 2003 B1
6511458 Milo et al. Jan 2003 B2
6514249 Maguire et al. Feb 2003 B1
6524251 Rabiner et al. Feb 2003 B2
6533766 Patterson et al. Mar 2003 B1
6544215 Bencini et al. Apr 2003 B1
6547754 Evans et al. Apr 2003 B1
6547788 Maguire et al. Apr 2003 B1
6551337 Rabiner et al. Apr 2003 B1
6554846 Hamilton et al. Apr 2003 B2
6555059 Myrick et al. Apr 2003 B1
6558502 Divino, Jr. et al. May 2003 B2
6562031 Chandrasekaran et al. May 2003 B2
6573470 Brown et al. Jun 2003 B1
6576807 Brunelot et al. Jun 2003 B1
6582387 Derek et al. Jun 2003 B2
6589253 Cornish et al. Jul 2003 B1
6595989 Schaer Jul 2003 B1
6596235 Divino, Jr. et al. Jul 2003 B2
6602467 Divino, Jr. et al. Aug 2003 B1
6602468 Patterson et al. Aug 2003 B2
6605217 Buhr et al. Aug 2003 B2
6607698 Spears et al. Aug 2003 B1
6610077 Hancock et al. Aug 2003 B1
6613280 Myrick et al. Sep 2003 B2
6615062 Ryan et al. Sep 2003 B2
6616617 Ferrera et al. Sep 2003 B1
6622542 Derek et al. Sep 2003 B2
6623448 Slater Sep 2003 B2
6635017 Moehring et al. Oct 2003 B1
6650923 Lesh et al. Nov 2003 B1
6652547 Rabiner et al. Nov 2003 B2
6660013 Rabiner et al. Dec 2003 B2
6676900 Divino, Jr. et al. Jan 2004 B1
6682502 Bond et al. Jan 2004 B2
6685657 Jones Feb 2004 B2
6689086 Nita et al. Feb 2004 B1
6695781 Rabiner et al. Feb 2004 B2
6695782 Ranucci et al. Feb 2004 B2
6695810 Peacock, III et al. Feb 2004 B2
6702748 Nita et al. Mar 2004 B1
6702750 Yock Mar 2004 B2
6719715 Newman et al. Apr 2004 B2
6719725 Milo et al. Apr 2004 B2
6729334 Baran May 2004 B1
6733451 Rabiner et al. May 2004 B2
6758846 Goble et al. Jul 2004 B2
6761698 Shibata et al. Jul 2004 B2
6814727 Mansouri-Ruiz Nov 2004 B2
6855123 Nita Feb 2005 B2
6866670 Rabiner et al. Mar 2005 B2
6936025 Evans et al. Aug 2005 B1
6936056 Nash et al. Aug 2005 B2
6942620 Nita et al. Sep 2005 B2
6942677 Nita et al. Sep 2005 B2
6955680 Satou et al. Oct 2005 B2
7004173 Sparks et al. Feb 2006 B2
7004176 Lau Feb 2006 B2
7056294 Khairkhahan et al. Jun 2006 B2
7115134 Chambers Oct 2006 B2
7131983 Murakami Nov 2006 B2
7137963 Nita et al. Nov 2006 B2
7149587 Wardle et al. Dec 2006 B2
7150853 Lee et al. Dec 2006 B2
7166098 Steward et al. Jan 2007 B1
7220233 Nita et al. May 2007 B2
7267650 Chow et al. Sep 2007 B2
7297131 Nita Nov 2007 B2
7335180 Nita et al. Feb 2008 B2
7341569 Soltani et al. Mar 2008 B2
7384407 Rodriguez et al. Jun 2008 B2
7393338 Nita Jul 2008 B2
7421900 Karasawa et al. Sep 2008 B2
7425198 Moehring et al. Sep 2008 B2
7494468 Rabiner et al. Feb 2009 B2
7503895 Rabiner et al. Mar 2009 B2
7540852 Nita et al. Jun 2009 B2
7604608 Nita et al. Oct 2009 B2
7621902 Nita et al. Nov 2009 B2
7621929 Nita et al. Nov 2009 B2
7628763 Noriega et al. Dec 2009 B2
7648478 Soltani et al. Jan 2010 B2
7758510 Nita et al. Jul 2010 B2
7771358 Moehring et al. Aug 2010 B2
7771452 Pal et al. Aug 2010 B2
7775994 Lockhart Aug 2010 B2
7776025 Bobo, Jr. Aug 2010 B2
7819013 Chan et al. Oct 2010 B2
7850623 Griffin et al. Dec 2010 B2
7918819 Karmarkar et al. Apr 2011 B2
7935108 Baxter et al. May 2011 B2
7938819 Kugler et al. May 2011 B2
7942809 Leban May 2011 B2
7955293 Nita et al. Jun 2011 B2
7993308 Rule et al. Aug 2011 B2
8038693 Allen Oct 2011 B2
8043251 Nita et al. Oct 2011 B2
8052607 Byrd Nov 2011 B2
8083727 Kugler et al. Dec 2011 B2
8133236 Nita Mar 2012 B2
8152753 Nita et al. Apr 2012 B2
8172758 Harhen May 2012 B2
8221343 Nita et al. Jul 2012 B2
8226566 Nita Jul 2012 B2
8246643 Nita Aug 2012 B2
8257378 O'connor Sep 2012 B1
8308677 Nita et al. Nov 2012 B2
8343134 Kost et al. Jan 2013 B2
8414543 Mcguckin, Jr. et al. Apr 2013 B2
8496669 Nita et al. Jul 2013 B2
8506519 Nita Aug 2013 B2
8613700 Ueno et al. Dec 2013 B2
8613751 Nita et al. Dec 2013 B2
8617096 Nita et al. Dec 2013 B2
8632560 Pal et al. Jan 2014 B2
8641630 Nita et al. Feb 2014 B2
8647293 Nita Feb 2014 B2
8647296 Moberg et al. Feb 2014 B2
8663259 Levine et al. Mar 2014 B2
8668709 Nita et al. Mar 2014 B2
8690818 Bennett et al. Apr 2014 B2
8690819 Nita et al. Apr 2014 B2
8702595 Ueki Apr 2014 B2
8708892 Sugiyama et al. Apr 2014 B2
8708994 Pettis et al. Apr 2014 B2
8725228 Koblish et al. May 2014 B2
8764700 Zhang et al. Jul 2014 B2
8768433 Jenkins et al. Jul 2014 B2
8790291 Nita et al. Jul 2014 B2
8974446 Nguyen et al. Mar 2015 B2
8978478 Ishioka Mar 2015 B2
9101387 Plowe et al. Aug 2015 B2
9107590 Hansmann et al. Aug 2015 B2
9237837 Omoto et al. Jan 2016 B2
9265520 Nita Feb 2016 B2
9282984 Nita Mar 2016 B2
9314258 Nita et al. Apr 2016 B2
9381027 Nita et al. Jul 2016 B2
9421024 Nita et al. Aug 2016 B2
9433433 Nita et al. Sep 2016 B2
9603615 Sarge Mar 2017 B2
9770250 Nita et al. Sep 2017 B2
9955994 Nita May 2018 B2
10004520 Nita et al. Jun 2018 B2
10130380 Nita et al. Nov 2018 B2
10285727 Nita May 2019 B2
20020022858 Demond et al. Feb 2002 A1
20020049409 Noda et al. Apr 2002 A1
20020077550 Rabiner et al. Jun 2002 A1
20020188276 Evans et al. Dec 2002 A1
20020189357 Lai et al. Dec 2002 A1
20030009153 Brisken et al. Jan 2003 A1
20030036705 Hare et al. Feb 2003 A1
20030040762 Dorros et al. Feb 2003 A1
20030199817 Thompson et al. Oct 2003 A1
20030216732 Truckai et al. Nov 2003 A1
20030225332 Okada et al. Dec 2003 A1
20040019349 Fuimaono et al. Jan 2004 A1
20040024393 Nita et al. Feb 2004 A1
20040054367 Teodoro, Jr. et al. Mar 2004 A1
20040164030 Lowe et al. Aug 2004 A1
20040167511 Buehlmann et al. Aug 2004 A1
20040193033 Badehi et al. Sep 2004 A1
20050033311 Guldfeldt et al. Feb 2005 A1
20050149110 Wholey et al. Jul 2005 A1
20050165388 Bhola Jul 2005 A1
20050171527 Bhola Aug 2005 A1
20050228286 Messerly et al. Oct 2005 A1
20060074441 Mcguckin, Jr. et al. Apr 2006 A1
20060149169 Nunomura et al. Jul 2006 A1
20060206039 Wilson et al. Sep 2006 A1
20060264809 Hansmann et al. Nov 2006 A1
20070032749 Overall et al. Feb 2007 A1
20070161945 Nita et al. Jul 2007 A1
20070178768 Harshman et al. Aug 2007 A1
20080033284 Hauck Feb 2008 A1
20080071343 Mayberry et al. Mar 2008 A1
20080208084 Horzewski et al. Aug 2008 A1
20080221506 Rodriguez et al. Sep 2008 A1
20080294037 Richter Nov 2008 A1
20090017293 Arai et al. Jan 2009 A1
20090143795 Robertson Jun 2009 A1
20100004558 Frankhouser et al. Jan 2010 A1
20100023037 Nita et al. Jan 2010 A1
20100069854 Okoh et al. Mar 2010 A1
20100076454 Bos Mar 2010 A1
20100121144 Farhadi May 2010 A1
20100217306 Raabe et al. Aug 2010 A1
20100268206 Manwaring et al. Oct 2010 A1
20110046522 Chan et al. Feb 2011 A1
20110105960 Wallace May 2011 A1
20110130834 Wilson et al. Jun 2011 A1
20110196399 Robertson et al. Aug 2011 A1
20110196403 Robertson et al. Aug 2011 A1
20110237982 Wallace Sep 2011 A1
20110313328 Nita Dec 2011 A1
20120010506 Ullrich Jan 2012 A1
20120109021 Hastings et al. May 2012 A1
20120130475 Shaw May 2012 A1
20120217306 Morrill Webb et al. Aug 2012 A1
20120238916 Nita et al. Sep 2012 A1
20120238946 Nita et al. Sep 2012 A1
20120311844 Nita et al. Dec 2012 A1
20120330196 Nita Dec 2012 A1
20130046297 Lingeman et al. Feb 2013 A1
20130060169 Yamada Mar 2013 A1
20130331652 Okamoto Dec 2013 A1
20130338580 Yamatani et al. Dec 2013 A1
20140005706 Gelfand et al. Jan 2014 A1
20140012087 Omoto Jan 2014 A1
20140039491 Bakos et al. Feb 2014 A1
20140171804 Van Hoven Jun 2014 A1
20140236118 Unser et al. Aug 2014 A1
20140243712 Humayun et al. Aug 2014 A1
20140350401 Sinelnikov Nov 2014 A1
20140358028 Vetter et al. Dec 2014 A1
20140358029 Vetter et al. Dec 2014 A1
20150025544 Nita et al. Jan 2015 A1
20150073357 Bagwell et al. Mar 2015 A1
20150105621 Farhadi Apr 2015 A1
20150105715 Pikus et al. Apr 2015 A1
20150133918 Sachar May 2015 A1
20150148795 Amos et al. May 2015 A1
20150157443 Hauser et al. Jun 2015 A1
20150190660 Sarge et al. Jul 2015 A1
20150297258 Escudero et al. Oct 2015 A1
20150359651 Wübbeling Dec 2015 A1
20160128717 Nita May 2016 A1
20160128767 Azamian et al. May 2016 A1
20160135835 Onuma May 2016 A1
20160183956 Nita Jun 2016 A1
20160271362 Van Liere Sep 2016 A1
20160328998 Nita et al. Nov 2016 A1
20160367284 Nita et al. Dec 2016 A1
20170065288 Imai et al. Mar 2017 A1
20170128090 Sarge May 2017 A1
20170224375 Robertson et al. Aug 2017 A1
20170265879 Washburn, II et al. Sep 2017 A1
20170265886 Nita et al. Sep 2017 A1
20170354428 Nita et al. Dec 2017 A1
20180042636 Nita Feb 2018 A1
20180140321 Deepa May 2018 A1
20180168668 Zheng Jun 2018 A1
20180177515 Boyle et al. Jun 2018 A1
20180197856 Chou et al. Jul 2018 A1
20180221040 Roll Hoye Aug 2018 A1
20180280005 Parmentier Oct 2018 A1
20180280044 Nita et al. Oct 2018 A1
Foreign Referenced Citations (73)
Number Date Country
2007240154 Jan 2008 AU
2256127 May 1974 DE
2438648 Feb 1976 DE
8910040 Dec 1989 DE
3821836 Jan 1990 DE
4042435 Feb 1994 DE
10146011 Apr 2003 DE
0005719 Dec 1979 EP
0316789 May 1989 EP
0316796 May 1989 EP
0376562 Jul 1990 EP
0379156 Jul 1990 EP
0394583 Oct 1990 EP
0443256 Aug 1991 EP
0472368 Feb 1992 EP
0541249 May 1993 EP
0820728 Jan 1998 EP
1323481 Jul 2003 EP
1106957 Mar 1968 GB
H2-7150 Oct 1988 JP
01-099547 Apr 1989 JP
6086822 Mar 1994 JP
H07500752 Jan 1995 JP
7116260 May 1995 JP
9-503137 Mar 1997 JP
10-216140 Aug 1998 JP
2000-291543 Oct 2000 JP
2001-104356 Apr 2001 JP
2001-321388 Nov 2001 JP
2002-186627 Jul 2002 JP
2005-253874 Sep 2005 JP
2006-522644 Oct 2006 JP
2007512087 May 2007 JP
2007520255 Jul 2007 JP
8705739 Sep 1987 WO
8705793 Oct 1987 WO
8906515 Jul 1989 WO
9001300 Feb 1990 WO
9004362 May 1990 WO
9107917 Jun 1991 WO
9211815 Jul 1992 WO
9308750 May 1993 WO
9316646 Sep 1993 WO
9412140 Jun 1994 WO
9414382 Jul 1994 WO
9508954 Apr 1995 WO
9509571 Apr 1995 WO
9515192 Jun 1995 WO
9635469 Nov 1996 WO
9705739 Feb 1997 WO
9721462 Jun 1997 WO
9745078 Dec 1997 WO
9827874 Jul 1998 WO
9835721 Aug 1998 WO
9851224 Nov 1998 WO
9852637 Nov 1998 WO
9925412 May 1999 WO
0053341 Sep 2000 WO
0067830 Nov 2000 WO
02094103 Nov 2002 WO
03039381 May 2003 WO
2004012609 Feb 2004 WO
2004093736 Nov 2004 WO
2004112888 Dec 2004 WO
2005053769 Jun 2005 WO
2005112770 Dec 2005 WO
2006049593 May 2006 WO
2013109269 Jul 2013 WO
2014022716 Feb 2014 WO
2014105754 Jul 2014 WO
2014106847 Jul 2014 WO
2018097856 May 2018 WO
20180187159 Oct 2018 WO
Non-Patent Literature Citations (29)
Entry
Japanese Office Action for Japanese Application No. 2010-134566, dated Mar. 2, 2012.
Sehgal, et al., Ultrasound-Assisted Thrombolysis, Investigative Radiology, 1993, vol. 28, Issue 10, pp. 939-943.
Siegel, et al., “In Vivo Ultrasound Arterial Recanalization of Atherosclerotic Total Occlusions”, Journal of the American College of Cardiology, Feb. 1990, vol. 15, No. 2, pp. 345-351.
“What is Electron Beam Curing?” downloaded from web on Nov. 14, 2002, 4 pages total. <http://www.ms.oml.gov/researchgroups/composites/new%20orccmt%20pages/pages/ebwha>.
EP Extended Search Report dated Aug. 13, 2009; Application 04710537.5-1269, 5 pages.
Extended European Search Report dated Mar. 5, 2012 for European Application No. 12153606.4-1269.
Margaret Fyfe et al., Mast cell degranulation and increased vascular permeability induced by therapeutic ultrasound in the rate ankle joint, Br. J. exp. Path., 1984, vol. 65, pp. 671-676.
“Irradiation, Biological, and Other Technologies: E-beam, Biological, and Sharps Treatment Systems”, Non-Incineration Medical Waste Treatment Technologies, Aug. 2001, Chapter 9, pp. 69-74, Health Care Without Harm, Washington, DC.
Paul Yock et al., Catheter-Based Ultrasound Thrombolysis Shake, Rattle, and Repertuse, https://doi.org/10.1161/01.CIR.95.6.1360 Circulation. 1997;95:1360-1362 Originally published Mar. 18, 1997.
Calhoun et al., “Electron-Beam Systems for Medical Device Sterilization”, downloaded from web on Oct. 8, 2002 <http://www.devicelink.com/mpb/archive/97/07/002.html> 7 pages total.
Definition of the term “coupled”, retrieved on May 18, 2013. <http://www.merriam-webster.com/dictionary/couple> 1 page total.
“E-Beam Theory” RDI-IBA Technology Group, downloaded from web on Oct. 8, 2002 <http://www.e-beamrdi/EbeamTheory.htm> 2 pages total.
Office Action dated May 20, 2010 from Japanese Application No. 2006-541200 filed on Oct. 25, 2004.
Office Action dated Oct. 11, 2012 from Japanese Application No. 2010-181956.
Noone, D.: Experimental and Numerical Investigation of Wire Waveguides for Therapeutic Ultrasound Angioplasty. M.Eng. Dublin City University. 2008.
Definition of the term “connected”, retrieved on Sep. 21, 2013. <www.thefreedictionary.com/connected> 1 page total.
Supplemental European Search Report dated Nov. 5, 2009 for European Application No. EP03766931.
International Search Report dated Oct. 28, 2003 for PCT Application No. PCT/US2003/023468.
Extended European Search Report dated Mar. 22, 2012 for European Application No. EP11188799.
International Search Report dated Dec. 23, 2005 for PCT Application No. PCT/US2004/019378.
Extended European Search Report for Patent Application No. 06718204.8, dated May 30, 2012.
International Search Report dated Aug. 1, 2013 for PCT Application No. PCT/US2013/053306.
International Preliminary Report dated Aug. 1, 2013 for PCT Application No. PCT/US2013/053306.
Written Opinion dated Aug. 1, 2013 for PCT Application No. PCT/US2013/053306.
Supplemental European Search Report dated Apr. 29, 2009 for European Application No. EP 04711207.3.
Office Action dated Aug. 3, 2010 from Japanese Application No. 2006-517355 filed on Jun. 16, 2004.
Office Action dated Jan. 26, 2010 from Japanese Application No. 2006-517355 filed on Jun. 16, 2004.
International Preliminary Report and Written Opinion dated Aug. 1, 2017 for PCT Application No. PCT/US2017/030675.
International Preliminary Report and Written Opinion dated Feb. 6, 2018 for PCT Application No. PCT/US2018/017022.
Related Publications (1)
Number Date Country
20190216487 A1 Jul 2019 US
Divisions (2)
Number Date Country
Parent 14201649 Mar 2014 US
Child 15229034 US
Parent 10722209 Nov 2003 US
Child 12036870 US
Continuations (2)
Number Date Country
Parent 15229034 Aug 2016 US
Child 16368095 US
Parent 12036870 Feb 2008 US
Child 14201649 US